PROF
PROF
NASDAQ · Health Care

Profound Medical Corp

$7.42
-0.02 (-0.27%)
Financial Highlights (FY 2026)
Revenue
26.16M
Net Income
-69,181,770
Gross Margin
70.8%
Profit Margin
-264.4%
Rev Growth
+34.1%
D/E Ratio
0.07
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 70.8% 70.8% 58.7% 58.7%
Operating Margin -256.3% -230.6% 13.1% 12.1%
Profit Margin -264.4% -251.2% 10.1% 13.3%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 26.16M 19.52M 110.97M 130.03M
Gross Profit 18.52M 13.81M 65.14M 76.33M
Operating Income -67,046,413 -45,011,018 14.49M 15.72M
Net Income -69,181,770 -46,444,571 11.22M 17.35M
Gross Margin 70.8% 70.8% 58.7% 58.7%
Operating Margin -256.3% -230.6% 13.1% 12.1%
Profit Margin -264.4% -251.2% 10.1% 13.3%
Rev Growth +34.1% +34.1% +15.1% +0.3%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 12.23M 12.23M 159.28M 166.07M
Total Equity 180.61M 180.61M 201.01M 174.26M
D/E Ratio 0.07 0.07 0.79 0.95
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -66,435,330 -47,078,594 16.88M 21.68M
Free Cash Flow — — 17.89M 15.74M